您好，欢迎访问中国农业科学院 机构知识库！

全部

  • 全部
  • 标题
  • 学者
  • 机构
  • 关键词

In vitro fermentation of epilactose and epilactitol by human faecal microbiota

文献类型： 外文期刊

作者： Zhang, Yuwei 1 ; Qiao, Yu 1 ; Xu, Xiaoqing 1 ; Peng, Qing 1 ; Ren, Jinwei 2 ; Ma, Lan 1 ; Tian, Dandan 1 ; Gong, Yuxin 1 ; Feng, Deqin 3 ; Shi, Bo 1 ;

作者机构： 1.Chinese Acad Agr Sci, Feed Res Inst, Beijing 100081, Peoples R China

2.Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing 100101, Peoples R China

3.Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources & Early Dev, Beijing 100101, Peoples R China

期刊名称：INTERNATIONAL DAIRY JOURNAL （ 影响因子：3.1； 五年影响因子：3.2 ）

ISSN： 0958-6946

年卷期： 2023 年 144 卷

页码：

收录情况： SCI

摘要： To obtain new lactose-derived prebiotic, epilactose and its derivative epilactitol were synthesised with high purity (>98%), and their structural characteristics were investigated. To determine the prebiotic potential of epilactose and epilactitol, these two compounds were fermented in vitro with human faecal microbiota. Consequently, epilactose addition increased the relative abundance of Bifidobacterium, Megamonas, Blautia, and Phascolarctobacterium, whereas epilactitol addition enhanced the relative abundance of Anaerostipes, Megamonas, Blautia and Phascolarctobacterium after in vitro fermentation for 24 h. The two compounds increased the production of total amount of short-chain fatty acids (SCFAs); in particular, epilactose addition increased acetate and n-butyrate production (P < 0.05), and epilactitol addition increased propionate and n-butyrate production (P < 0.05) after in vitro fermentation for 24 h. In conclusion, epilactose and epilactitol can be utilised by human faecal microbiota, modify microbial community, increase SCFA production, they may serve as novel prebiotics to bring health benefits for humans.(c) 2023 Elsevier Ltd. All rights reserved.

  • 相关文献
作者其他论文 更多>>
置顶
购物车
反馈

© 京ICP备09089781号-29 主办单位：中国农业科学院

学术资源： 中国农业科学院 农业专业知识服务系统 农科联盟资源共建共享平台 中国农业科技文献与信息服务平台 中国农业期刊集成服务平台